Home
Career Stage
Medical Students Residents Attendings CPT Codes Resources Blog Support

J0565 Injection, bezlotoxumab, 10 milligrams

J Codes (Drugs)

Also known as: bezlotoxumab, InVixxe

Bezlotoxumab injection, 10 milligrams, a monoclonal antibody against Clostridioides difficile toxin B for prevention of recurrent infection.

In Plain Language

Clostridioides difficile prevention injection; infection recurrence preventer

Clinical Context

Indicated for patients at high risk of recurrent Clostridioides difficile infection (previous episodes, immunocompromised, advanced age). Administered intravenously as a single infusion during active infection treatment.

RVU Information

CPT J0565 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.

Billing & Documentation

J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.

Specialties

infectious diseasegastroenterologyhospital medicine

Frequently Asked Questions

What is CPT code J0565?

CPT J0565 (Injection, bezlotoxumab, 10 milligrams) is a J Codes (Drugs) code. Bezlotoxumab injection, 10 milligrams, a monoclonal antibody against Clostridioides difficile toxin B for prevention of recurrent infection.

How is J0565 administered?

CPT J0565 is administered by a healthcare provider, typically via injection or infusion. Indicated for patients at high risk of recurrent Clostridioides difficile infection (previous episodes, immunocompromised, advanced age). Administered intravenously as a single infusion during active infection treatment. It is used by infectious disease, gastroenterology, hospital medicine.

When is CPT J0565 used?

Indicated for patients at high risk of recurrent Clostridioides difficile infection (previous episodes, immunocompromised, advanced age). Administered intravenously as a single infusion during active infection treatment.

Track This Code in RVU Edge

Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.

CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.